Abstract:
When a company is developing several important new compounds and one is facing challenges in formulation development, it is important to establish whether the potential for the product with an alternative formulation would be viable in sales terms. The market research investigation, which was conducted in the United States, Japan and Europe with an overall total of 298 respondents, used an adaptive conjoint approach (ACA) together with several interesting interlocking questions to assess the importance of the dosage form. It was possible to assess and model market penetration which clearly showed the impact of not having the oral formulation. Despite this, the product based on the conjoint work backed up by evaluation of an outline profile, demonstrated a very significant sales opportunity. The project was a high profile study within Zeneca which helped to enhance the standing of marketing research input.
This could also be of interest:
Research Papers
Life after 50
Catalogue: Seminar 1991: The Over 50's In The 90's
Authors: Vicki Drummond, Greg Smith, Leon Kreitzman
Company: Nielsen
June 15, 1991
Research Papers
When marketing is a matter of life and death
Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future
Authors: Hazel Kahan, Dave Mulryan
 
June 15, 1997
Videos
The future of life insurance
Catalogue: Congress 2017: Visionary
Authors: Claudia Furniel, Gabriel Milanez, Luiza Baffa, Maisa Gennari
 
November 27, 2017
